DNAprint Genomics (DNAG)

[DougS.]

ok - I don't think that's plausible starting point. DNAP's plan is to create population specific medications that are bundled with a diagnostic test kits.

In order to have a competitive challenge, a pharma would not only need to have solid genomics capabilities (which they don't) but they would also already need a very similar test to go along with each particular drug. The entire package, drug and kit, are what will be getting FDA approval.

Sure pharma could copy the drug. Anyone can do that. After all, what the *hell* do you guys (I'm talking to you longs) think DNAP is doing in the first place? We're stealing from them! But this is a one way street until pharmas decide to think genomics. They can't do anything with the medications until they know how to apply them.